CAH

Cardinal Health
D

CAH

Arincen75/100B

Cardinal Health free cash flow 1990–2027

Cardinal Health's free cash flow in Q1 FY2027, the three months to 30 September 2026, was 1.24B USD, up 43.5% on the same quarter a year before. Cardinal Health's free cash flow over the last twelve months was 4.90B USD, up 10.1% on the twelve months before. In fiscal year 2026 it was 4.53B USD, up 144.6% on the year before.

Last updated 7 Nov 2026 · Next report 4 Feb 2027

Free cash flow

Free cash flow · +6.1% a year over 10 yearsFree cash flow margin

Growth

Fiscal yearPeriod endingFree cash flowGrowthFree cash flow marginOperating cash flowCapital expenditureFree cash flow per share
TTM30 Sept 20264.90B+10.09%1.90%5.60B-698.00M20.79
FY202630 Jun 20264.53B+144.59%1.78%5.17B-649.00M19.09
FY202530 Jun 20251.85B-43.09%0.83%2.40B-547.00M7.64
FY202430 Jun 20243.25B+37.58%1.43%3.76B-511.00M13.16
FY202330 Jun 20232.36B-13.60%1.15%2.84B-481.00M9.02
FY202230 Jun 20222.74B+34.80%1.51%3.12B-387.00M9.80
FY202130 Jun 20212.03B+28.01%1.25%2.43B-400.00M6.90
FY202030 Jun 20201.59B-33.79%1.04%1.96B-375.00M5.41
FY201930 Jun 20192.39B+0.42%1.64%2.72B-328.00M7.95
FY201830 Jun 20182.38B+199.12%1.74%2.77B-384.00M7.57
FY201730 Jun 2017797.00M-68.20%0.61%1.18B-387.00M2.49
FY201630 Jun 20162.51B+11.87%2.06%2.97B-465.00M7.59
FY201530 Jun 20152.24B-1.54%2.18%2.54B-300.00M6.69
FY201430 Jun 20142.28B+48.50%2.50%2.52B-249.00M6.59
FY201330 Jun 20131.53B+67.80%1.52%1.73B-195.00M4.45
FY201230 Jun 2012913.00M-17.25%0.85%1.18B-263.00M2.62
FY201130 Jun 20111.10B-41.26%1.07%1.39B-291.30M3.13
FY201030 Jun 20101.88B+81.67%1.91%2.13B-255.80M5.20
FY200930 Jun 20091.03B-8.99%1.08%1.57B-533.40M2.86
FY200830 Jun 20081.14B+31.22%1.30%1.51B-376.10M3.12
FY200730 Jun 2007865.70M-48.99%1.00%1.22B-357.40M2.14
FY200630 Jun 20061.70B-25.52%2.13%2.14B-443.20M3.96
FY200530 Jun 20052.28B+2.89%3.14%2.85B-571.70M5.23
FY200430 Jun 20042.21B+127.17%3.43%2.62B-410.20M5.15
FY200330 Jun 2003974.80M+39.56%1.72%1.40B-423.20M2.15
FY200230 Jun 2002698.50M+31.67%1.37%983.90M-285.40M1.54
FY200130 Jun 2001530.50M+60.56%1.11%871.70M-341.20M1.14
FY200030 Jun 2000330.40M—0.86%638.20M-307.80M0.73
FY199930 Jun 1999-121.70M-528.52%-0.48%345.70M-467.40M-0.28
FY199830 Jun 199828.40M—0.13%143.10M-114.70M0.07
FY199730 Jun 1997-36.00M-173.32%-0.20%39.20M-75.20M-0.15
FY199630 Jun 199649.10M—0.53%122.20M-73.10M0.21
FY199530 Jun 1995-32.50M—-0.39%10.50M-43.00M-0.23
FY199430 Jun 1994-86.20M-185.18%-1.49%-74.90M-11.30M-0.52
FY199330 Jun 1993101.20M—5.15%106.50M-5.30M1.17
FY199230 Jun 1992-102.70M—-6.23%-93.80M-8.90M-1.22
FY199130 Jun 1991-34.30M-346.76%-2.90%-23.40M-10.90M-0.47
FY199030 Jun 199013.90M—1.59%17.70M-3.80M0.21

Figures in USD. Free cash flow is operating cash flow less capital expenditure. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Stock buybacks,Cash flow

Common questions about Cardinal Health's free cash flow

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.